Dr. William Lee Johnson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1102 Saint Marys Rd, Junction City, KS 66441 Phone: 785-210-3356 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that they have initiated a Phase 3 clinical trial evaluating the efficacy and safety of EYLEA (aflibercept) Injection in the neovascular form of age-related macular degeneration (wet AMD) in China.
A new KU Leuven study shows for the first time that the dampening or suppression of positive emotions plays an important role in the development of postpartum depression. This has implications for the treatment of depressed mothers.
A new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment.
If you've ever stopped to watch rain falling on a windowpane, you've seen what happens when two drops of water touch and merge into one.
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.
› Verified 9 days ago